Why is Krebs Biochem falling/rising?

As of 22-Sep, Krebs Biochemicals & Industries Ltd is experiencing a price increase, currently at Rs 81.00, reflecting a rise of 2.65 (3.38%). The stock has shown a positive performance today, outperforming its sector by 4.46%, and has gained consecutively over the last two days, with a total increase of 3.63% during this period. Despite these short-term gains, the company faces significant challenges, including a negative book value and weak long-term fundamental strength, as evidenced by a decline in net sales and operating profit over the past five years. The company has also reported negative results for the last three consecutive quarters, which has contributed to its overall negative sentiment in the market.
In the broader market context, Krebs Biochem's short-term performance has been notably better than the benchmark, with a 1-week return of +8.00% compared to the Sensex's +0.46%. However, the stock's long-term performance remains concerning, as it has underperformed against the benchmark over the past three years, with a year-to-date return of -12.43% compared to the Sensex's +5.15%. This consistent underperformance, combined with high debt levels and a negative EBITDA, suggests that while the stock may be experiencing a temporary rise, the underlying fundamentals indicate a risky investment environment.